Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Female
Breast Cancer
Female
Breast Cancer
Trial Information
Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer
Inclusion Criteria:
- Women with at least two finished lines of hormonal treatment for advanced breast
cancer Tumor markers (CEA. CA15-3) values available at the time of onset and
discontinuation of therapy Imaging methods results available at the time of onset and
discontinuation of therapy
Exclusion Criteria:
- None
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Outcome Measure:
Reasons for change of hormonal therapy (biochemical progression, objective progression, symptomatic progression, safety reasons, other)
Outcome Time Frame:
Every 3 months
Safety Issue:
No
Principal Investigator
Ales Kminek
Investigator Role:
Study Director
Investigator Affiliation:
AstraZeneca Czech Republic
Authority:
Czech Republic: State Institute for Drug Control
Study ID:
NIS-OCZ-FAS-2010/1
NCT ID:
NCT01265654
Start Date:
January 2011
Completion Date:
November 2011
Related Keywords:
- Breast Cancer
- Advanced Breast Cancer
- Hormonal Treatment
- Breast Neoplasms
Name | Location |
|---|
